Clinical Trials Directory

Trials / Completed

CompletedNCT05286385

CP1150 Sound Processor Speech Perception Compared With the Next Generation of Signal Processing Technology

A Pre-Marketing, Prospective, Single-Site, Open-Label, Within-Subject, Pilot, Interventional Study of Adult Cochlear Implant Speech Perception With the CP1150 Sound Processor Compared With the Next Generation of Signal Processing Technology

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Cochlear · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This clinical study aims to investigate speech performance in quiet with an OTE Sound Processor with modified firmware compared with the commercially available CP1150. The study also investigates CP1110 and CP1150 with Forward Focus.

Detailed description

This study will build on the evidence previously collected on OTE and BTE Sound Processors and will support the design goals for access to the same sound processing algorithms across future OTE and BTE variants, including evidence required on the automation of FF and future implant compatibility.

Conditions

Interventions

TypeNameDescription
DEVICECP1150 Sound ProcessorSpeech perception tests whilst the subject is fitted with the CP1150 Sound Processor
DEVICECP1150 NFSpeech perception tests whilst the subject is fitted with the CP1150 modified firmware (the addition of notch filters at 978Hz, 1956Hz, 2934Hz, 3912Hz).
DEVICECP1150 + FFSpeech perception tests whilst the subject is fitted with the CP1150 Sound Processor with ForwardFocus.
DEVICECP1110Speech perception tests whilst the subject is fitted with the CP1110 Sound Processor.

Timeline

Start date
2022-05-30
Primary completion
2022-06-29
Completion
2022-06-29
First posted
2022-03-18
Last updated
2025-02-07
Results posted
2024-08-05

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT05286385. Inclusion in this directory is not an endorsement.